Table 1 Frequency of represented disciplines and methodologies applied in each discipline
From: A systematic review of moral reasons on orphan drug reimbursement
Discipline | Methodology | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Theoretical/comments/editorials | Empirical | Reviews | Policy guidelines | Legal | Other | Total | ||||||||
Philosophy/bioethics | 25 (86%) | 0 (0%) | 3 (10%) | 1 (3%) | 0 (0%) | 0 (0%) | 29 (100%) | |||||||
Clinical medicine | 12 (57%) | 3 (14%) | 4 (19%) | 1 (5%) | 1 (5%) | 0 (0%) | 21 (100%) | |||||||
Health economics | 21 (43%) | 12 (24%) | 16 (33%) | 0 (0%) | 0 (0%) | 0 (0%) | 49 (100%) | |||||||
Health policy | 31 (30%) | 21 (20%) | 42 (41%) | 7 (7%) | 1 (1%) | 1 (1%) | 103 (100%) | |||||||
Law | 2 (22%) | 0 (0%) | 1 (11%) | 0 (0%) | 6 (67%) | 0 (0%) | 9 (100%) | |||||||
Social sciences | 0 (0%) | 18 (90%) | 1 (5%) | 0 (0%) | 0 (0%) | 1 (5%) | 20 (100%) | |||||||
Industry (stakeholder) | 1 (25%) | 0 (0%) | 0 (0%) | 3 (75%) | 0 (0%) | 0 (0%) | 4 (100%) | |||||||
Patients (stakeholder) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (100%) | 0 (0%) | 0 (0%) | 3 (100%) | |||||||
Other | 0 (0%) | 0 (0%) | 0 (0%) | 3 (60%) | 0 (0%) | 2 (40%) | 5 (100%) | |||||||
Total | 92 (38%) | 54 (22%) | 67 (28%) | 18 (7%) | 8 (3%) | 4 (2%) | 243 (100%) | |||||||